Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Amparo Garcia-TejedorSergi Fernandez-GonzalezRaul OrtegaMiguel Gil-GilHector Perez-MonteroEulalia Fernandez-MontolíAgostina StradellaSabela RecaldeTeresa SolerAnna PetitMaria Teresa BajenAna BenitezAnna GumaMiriam CamposMaria J PlaEvelyn MartinezMaria LaplanaSonia PernasDiana Perez-SildekovaIsabel CatalaJordi PonceCatalina FaloPublished in: Breast cancer research and treatment (2020)
In HER2-positive and triple-negative breast cancer patients staged as cN2 or with high axillary burden before NACT, a sentinel lymph node biopsy after NACT could be recommended if there is a clinical and radiological response.